This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Marcos, A. Articles by Cabranes, J. A. Search for Related Content PubMed PubMed Citation Articles by Marcos, A. Articles by Cabranes, J. A. Social Bookmarking                         What's this?

Neuropsychological Markers of Progression From Mild Cognitive Impairment to Alzheimer’s Disease

Neurology Department, Hospital Clínico San Carlos, Madrid, Spain, a_marcos_d{at}yahoo.es

Pedro Gil, PhD

Neurology Department, Hospital Clínico San Carlos, Madrid, Spain

Ana Barabash, MD

Neurology Department, Hospital Clínico San Carlos, Madrid, Spain

Raquel Rodriguez

Neurology Department, Hospital Clínico San Carlos, Madrid, Spain

Marta Encinas, MD

Neurology Department, Hospital Clínico San Carlos, Madrid, Spain

Cristina Fernández, MD

Neurology Department, Hospital Clínico San Carlos, Madrid, Spain

José Antonio Cabranes, PhD

Neurology Department, Hospital Clínico San Carlos, Madrid, Spain

To find early clinical markers that may predict a likely progression to Alzheimer’s disease (AD), the authors performed neuropsychological tests on 82 mild cognitive impairment (MCI) subjects. After 3 years, 38 patients developed AD while 44 retained the diagnosis of MCI. The cognitive differences between the groups were studied. Patients who developed AD showed significantly lower values than did MCI subjects in some neuropsychological scores (P = .02-.001), with sensitivities and specificities higher than 84% and 64%, respectively, for detecting early-onset AD, with a 7.9-fold increased risk of converting to AD (P < .001). Regarding the logistic regression model, the CAMCOG Memory and Perception cognitive screening items were the optimum independent tools to classify the patients who will progress to AD, showing a relative risk of progression of 10.5 (P = .002), 5.5 (P = .008), and 3.9 times (P = .05), respectively, with a sensibility of of 92.1% and a specificity 72.7%.

Key Words: mild cognitive impairment • Alzheimer’s disease • neuropsychological test • preclinical markers

American Journal of Alzheimer's Disease and Other Dementias®, Vol. 21, No. 3, 189-196 (2006)
DOI: 10.1177/1533317506289348


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. Heinik and D. Shaikewitz The Clock Drawing Test--Modified and Integrated Approach (CDT-MIA) as an Instrument for Detecting Mild Cognitive Impairment in a Specialized Outpatient Setting J Geriatr Psychiatry Neurol, September 1, 2009; 22(3): 171 - 180. [Abstract] [PDF]